Dr. Mark A. Taylor
Claim this profileLewis Cancer and Research Pavilion at Saint Joseph's/Candler
Area of expertise
Lung Cancer
Mark A. Taylor has run 12 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Mark A. Taylor has run 7 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Lewis Cancer And Research Pavilion At Saint Joseph's/Candler
Saint Joseph's/Candler - Bluffton Campus
Clinical Trials Mark A. Taylor is currently running
Ribociclib + Hormone Therapy
for Breast Cancer
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Recruiting
2 awards
Phase 3
4 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
More about Mark A. Taylor
Clinical Trial Related
9 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Mark A. Taylor has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Crizotinib
- Larotrectinib
- Abemaciclib
Breakdown of trials Mark A. Taylor has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark A. Taylor specialize in?
Mark A. Taylor focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Mark A. Taylor currently recruiting for clinical trials?
Yes, Mark A. Taylor is currently recruiting for 8 clinical trials in Savannah Georgia. If you're interested in participating, you should apply.
Are there any treatments that Mark A. Taylor has studied deeply?
Yes, Mark A. Taylor has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Mark A. Taylor?
Apply for one of the trials that Mark A. Taylor is conducting.
What is the office address of Mark A. Taylor?
The office of Mark A. Taylor is located at: Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia 31405 United States. This is the address for their practice at the Lewis Cancer and Research Pavilion at Saint Joseph's/Candler.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.